Bovine Pericardial Valve Market Outlook and Strategic Insights by 2031

The bovine pericardial valve market size is projected to reach US$ 6.08 billion by 2031 from US$ 2.60 billion in 2022. The market is expected to register a CAGR of 9.9% in 2023–2031. Growing Reimbursement for cardiac valve surgeries is likely to remain a key Bovine Pericardial Valve market trend.

Bovine Pericardial Valve Market Analysis

Bovine pericardial valves are widely used in various medical applications, such as bio-prosthetic heart valves, dural closure, bone and dental membranes, and surgical buttressing. The growing number of heart valve interventions is expected to favor the development of new treatments to improve speech.  

Bovine Pericardial Valve Market Overview

The demand for bovine pericardial valves in cardiovascular surgeries such as aortic valve replacement and procedures for congenital heart diseases is rising due to their advantages over mechanical valves. The tissue valves, including bovine pericardium, can be used in minimally invasive surgery and in open-heart surgeries. The major advantage of these valves over mechanical valves is the avoidance of lifelong warfarin therapy to prevent the development of blood clots. Thus, the risk of stroke or embolism is low among patients preferring tissue valves to mechanical heart valves. Moreover, the bioprosthetic valves are an ideal choice for geriatric heart patients as they are more vulnerable to the bleeding side effects of warfarin during valve replacement surgery. Thus, the advantages offered by bovine pericardial bioprosthetic heart valves over mechanical valves are expected to foster the bovine pericardial valves market growth during the forecast period.

Bovine Pericardial Valve Market: Strategic Insights

Bovine Pericardial Valve Market Drivers and Opportunities

Mounting Prevalence of Heart Valve Diseases to Favor Market

The rising number of aortic replacement valve surgeries globally boosts the demand for bovine pericardial valves. According to an article published by the Interdisciplinary CardioVascular and Thoracic Surgery in January 2024, a clinical trial including 148 patients who underwent surgical aortic valve replacement with Cingular bovine pericardial bioprosthesis was analyzed. The 5-year follow-up study concluded that this novel bovine pericardial aortic valve exhibited good safety and hemodynamic outcomes.

Expanding Applications – An Opportunity in Paediatric and Congenital Heart Diseases

Bovine pericardial valves are used in pediatric heart valve replacements and congenital heart defect repairs

.

Bovine Pericardial Valve Market Report Segmentation Analysis

Key segments that contributed to deriving the Bovine Pericardial Valve Market analysis are valve type, alloy, and end user.

• Based on valve type, the bovine pericardial valve market is divided into aortic, mitral, and others. The aortic segment held a larger market share in 2023.
• By alloy, the market is segmented into cobalt-chrome, titanium, nickel molybdenum, and others. The cobalt-chrome segment held the largest share of the market in 2023.
• In terms of end-user, the market is segmented into hospitals, cardiac centers, and ambulatory surgical centers. The hospitals segment dominated the market in 2023.

Bovine Pericardial Valve Market Share Analysis by Geography

The geographic scope of the bovine pericardial valve Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Bovine Pericardial Valve Market. Factors such as the increasing prevalence of cardiovascular disorders, congenital heart defects, and the presence of leading market players in the region propel regional growth. Furthermore, the growing adoption of bioprostheses, such as bovine pericardial valves as an alternative to mechanical valves for heart valve interventions in the region, will further accelerate the North America bovine pericardial valve market growth. The market will likely experience growth opportunities in Canada and Mexico due to growing medical tourism and an increasing number of hospitals. Asia Pacific is likely to register the highest CAGR in the coming years.  

The regional trends and factors influencing the Bovine Pericardial Valve Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Bovine Pericardial Valve Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Bovine Pericardial Valve Market Report Scope

Bovine Pericardial Valve Market Players Density: Understanding Its Impact on Business Dynamics

The Bovine Pericardial Valve Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Bovine Pericardial Valve Market News and Recent Developments

The Bovine Pericardial Valve Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for bovine pericardial valves:

• Medtronic launched the Avalus Ultra valve, designed to facilitate ease of use at implant and lifetime patient management. The product is a next-generation surgical aortic tissue valve that features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) that allows for greater blood flow and a radiopaque coil for clear visibility for future valve-in-valve procedures (Source: Medtronic, Press Release, 2024)
• Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which incorporates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is a bovine pericardial tissue treated with advanced anti-calcification technology. It serves as the platform for new valves, including the next-generation SAPIEN X4 valve undergoing clinical trials. (Source: Edwards Lifesciences, Company Website, 2022)

Bovine Pericardial Valve Market Report Coverage and Deliverables

The “Bovine Pericardial Valve Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles